The announcement of a significant convertible note offering by Tandem Diabetes Care could be seen positively by investors as it indicates the company's proactive financial management and potential for future growth. The use of proceeds for capped call transactions and repurchasing existing notes and stock buybacks could also be viewed as a strong confidence signal by the management in the company's future, potentially leading to a short-term positive impact on TNDM's stock price.